This inventor holds 66 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 25 EPO patents, primarily in Cancer Immunotherapy (CPC class A61M). Top assignees: Miltenyi Biotec, Gmbh, Miltenyi Biotec B.v. Co., Kg, Lentigen Technology, Inc.. Active years: 1995-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Bergisch Gladbach DE (1996 - 1997)
- Gladbach, DE (1998)
- Cologne, DE (1995 - 2002)
- Bergische Gladbach, DE (2016 - 2021)
- Bergish Gladbach, DE (2018 - 2022)
- Bergisch Gladbach, DE (1997 - 2024)
Company Filing History:
29 out of 65 
15 out of 41 
6 out of 41 
Years Active: 1995-2026
Areas of Expertise:
Title: Innovations and Contributions of Stefan Miltenyi
Introduction
Stefan Miltenyi is a prominent inventor based in Bergisch Gladbach, Germany, known for his significant contributions to the fields of biotechnology and microfluidics. With an impressive portfolio of 57 patents, his work has paved the way for advancements in cell therapy and molecular biology.
Latest Patents
Miltenyi's latest patents showcase his expertise in innovative biotechnological solutions. One of his key inventions involves “Non-specific nucleases from the genus for use in facilitating the flow of cells through a microfluidic channel.” This composition provides an isolated polypeptide with non-specific nuclease activity, designed to degrade nucleic acids efficiently in controlled conditions. Additionally, he has developed a system for “Devices and disposables for patient-specific cell therapy manufacturing,” which comprises a sample processing unit that facilitates the separation of different components of deposited samples, enhancing the efficiency of cell therapy procedures.
Career Highlights
Throughout his career, Stefan Miltenyi has made remarkable strides in the biotech industry, particularly through his work with Miltenyi Biotec GmbH and Miltenyi Biotec B.V. & Co. KG. His innovative spirit and dedication to research have contributed significantly to the advancement of therapeutic technologies, making him a key figure in modern biomedicine.
Collaborations
In his professional journey, Miltenyi has collaborated with notable colleagues, including Eiad Kabaha and Winfried Schimmelpfennig. These alliances have allowed for the cross-pollination of ideas and expertise, further enriching his work and the impact it has had on the industry.
Conclusion
Stefan Miltenyi’s contributions to the fields of biotechnology and microfluidics have led to groundbreaking innovations that continue to shape the landscape of cell therapy. His extensive patent portfolio and collaborative efforts exemplify his commitment to advancing scientific knowledge and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile